The vulnerability dubbed “HamsterWheel” traps nodes in an endless loop similar to hamsters jogging on a wheel.
CertiKRead More
You might also be interested in reading Boehringer’s HERNEXEOS® approved in China as first oral targeted therapy for previously treated patients with HER2-mutant advanced NSCLC.